Get the Stockscreener App
0.5151
4.70%
0.0231
After Hours:
.52
0.0049
+0.95%
60 Degrees Pharmaceuticals Inc stock is traded at $0.5151, with a volume of 301.92K.
It is up +4.70% in the last 24 hours and down -47.08% over the past month.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.
See More
Previous Close:
$0.492
Open:
$0.5
24h Volume:
301.92K
Relative Volume:
1.71
Market Cap:
$2.18M
Revenue:
$502.40K
Net Income/Loss:
$-7.91M
P/E Ratio:
-0.0517
EPS:
-9.972
Net Cash Flow:
$-4.32M
1W Performance:
+1.88%
1M Performance:
-47.08%
6M Performance:
-78.36%
1Y Performance:
-91.89%
1-Day Range:
$0.4999
$0.5299
1-Week Range:
$0.4751
$0.5652
52-Week Range:
$0.45
$8.00
60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile
Name
60 Degrees Pharmaceuticals Inc
Sector
Industry
Phone
202-327-5422
Address
1025 CONNECTICUT AVENUE NW, WASHINGTON
Compare SXTP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SXTP
60 Degrees Pharmaceuticals Inc
|
0.5151 | 2.08M | 502.40K | -7.91M | -4.32M | -9.972 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
60 Degrees Pharmaceuticals Inc Stock (SXTP) Latest News
Processa Pharmaceuticals and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Bluffton Today
Enlivex Therapeutics and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Jackson Sun
60 Degrees Pharmaceuticals Inc. (NASDAQ:SXTP) Sees Large Growth in Short Interest - Defense World
60 Degrees Pharmaceuticals, Inc. Confirms Continuation of B-FREE Study to Assess ARAKODA® for Chronic Babesiosis Treatment - Quiver Quantitative
Tick-borne parasite found in 1 in 4 people with chronic fatigue in new study - Stock Titan
60 Degrees Pharmaceuticals Announces Detection of Babesia Infection in 24 Percent of Patients Presenting with Chronic Fatigue in Peer-Reviewed, Sponsored Study at NC State - Sahm
60 Degrees Pharmaceuticals and NDT Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Coloradoan
60 Degrees Pharmaceuticals Inc Stock (SXTP) Financials Data
Revenue
Net Income
Cash Flow
EPS
60 Degrees Pharmaceuticals Inc Stock (SXTP) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| DOW GEOFFREY S | President and CEO |
Dec 10 '25 |
Buy |
0.95 |
9,350 |
8,886 |
46,335 |
| DOW GEOFFREY S | President and CEO |
Dec 11 '25 |
Buy |
0.92 |
3,613 |
3,318 |
49,948 |
| XU CHERYL | Director |
Jun 03 '25 |
Buy |
2.88 |
5,000 |
14,410 |
15,816 |
2.52%
0.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):